Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Auriculotherapy in the Treatment of Pre-Operative Anxiety

NCT: NCT04836936 · RECRUITING

NCT IDNCT04836936
StatusRECRUITING
Start Date2021-04-13
Completion2026-06-30

Brief Summary

The goal of this clinical trial is to use the validated PROMIS Emotional Distress - Anxiety - Short Form 8a and PROMIS Emotional Distress-Depression-Short Form pre-and post-intervention to establish a superior correlation between the auriculotherapy treatment and the reduction of perioperative anxiety. Subject population will include those having a partial or total nephrectomy for cancer. Drawing the role that auriculotherapy may play in reducing perioperative anxiety related requirement after surgery may also help in reducing the risk of opioid use disorders (OUD) since anxiety has been found to be a major risk factor for OUD in surgical patients. Therefore, this trial will also examine the effect of the auriculotherapy intervention in reducing opioid requirement after surgery.

Frequently Asked Questions

What is Auriculotherapy in the Treatment of Pre-Operative Anxiety?

Auriculotherapy in the Treatment of Pre-Operative Anxiety is a clinical trial registered under NCT04836936. Current status: RECRUITING.

What is the status of NCT04836936?

The current status of NCT04836936 (Auriculotherapy in the Treatment of Pre-Operative Anxiety) is: RECRUITING.

When did Auriculotherapy in the Treatment of Pre-Operative Anxiety start?

Auriculotherapy in the Treatment of Pre-Operative Anxiety started on 2021-04-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.